Plum SEC

Korean Market
Privacy Policy

Korean Market

Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★

All Disclosures

PERI

TiumBio

★

TiumBio Reports Q1 2026 Operating Loss of KRW 4.5B; Positive Clinical Progress in Key Pipelines

05/15/2026, 12:15 PM

한국어 | English | 中文 | 日本語

Plum SEC © 2026.05.25

The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.